Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces

cg.authorship.typesCGIAR and developing country instituteen
cg.authorship.typesCGIAR and advanced research instituteen
cg.contributor.affiliationInternational Livestock Research Instituteen
cg.contributor.affiliationUniversity of Liverpoolen
cg.contributor.affiliationImperial College Londonen
cg.contributor.affiliationHammersmith Hospitalen
cg.contributor.affiliationAnimal and Plant Health Agency, New Haw, United Kingdomen
cg.contributor.affiliationUniversity of KwaZulu-Natalen
cg.contributor.affiliationUnited Kingdom Health Security Agencyen
cg.contributor.affiliationNewcastle Universityen
cg.contributor.affiliationUniversity of Ghanaen
cg.contributor.affiliationWellcome Trusten
cg.contributor.affiliationUniversity of Cambridgeen
cg.contributor.affiliationLiverpool School of Tropical Medicineen
cg.contributor.affiliationMalawi Liverpool Wellcome Research Programmeen
cg.contributor.affiliationUniversity of Sydneyen
cg.contributor.affiliationUniversity of Glasgowen
cg.contributor.donorBritish Society for Antimicrobial Chemotherapyen
cg.contributor.donorWellcome Trusten
cg.contributor.donorIlluminaen
cg.contributor.donorBill & Melinda Gates Foundationen
cg.contributor.donorUnited Kingdom Research and Innovationen
cg.contributor.donorNational Institute for Health Research, United Kingdomen
cg.contributor.donorBiotechnology and Biological Sciences Research Council, United Kingdomen
cg.contributor.donorMedical Research Council, United Kingdomen
cg.contributor.donorUnited Kingdom Health Security Agencyen
cg.contributor.donorRosetrees Trusten
cg.contributor.donorStoneygate Trusten
cg.creator.identifierDishon Muloi: 0000-0002-6236-2280
cg.howPublishedFormally Publisheden
cg.identifier.doihttps://doi.org/10.1016/s2666-5247(23)00284-7en
cg.isijournalISI Journalen
cg.issn2666-5247en
cg.issue12en
cg.journalLancet Microbeen
cg.reviewStatusPeer Reviewen
cg.subject.actionAreaResilient Agrifood Systems
cg.subject.ilriAMRen
cg.subject.ilriONE HEALTHen
cg.subject.impactAreaNutrition, health and food security
cg.subject.impactPlatformNutrition, Health and Food Security
cg.subject.sdgSDG 3 - Good health and well-beingen
cg.volume4en
dc.contributor.authorMuloi, Dishonen
dc.contributor.authorJauneikaite, E.en
dc.contributor.authorAnjum, M.F.en
dc.contributor.authorEssack, S.Y.en
dc.contributor.authorSingleton, D.A.en
dc.contributor.authorKasudi, M.R.en
dc.contributor.authorWade, M.J.en
dc.contributor.authorEgyir, B.en
dc.contributor.authorNunn, J.G.en
dc.contributor.authorMidega, J.T.en
dc.contributor.authorPeacock, S.J.en
dc.contributor.authorFeasey, N.A.en
dc.contributor.authorBaker, K.S.en
dc.contributor.authorZadoks, R.N.en
dc.contributor.authorSEDRIC Genomics Surveillance Working Groupen
dc.date.accessioned2023-11-15T10:37:15Zen
dc.date.available2023-11-15T10:37:15Zen
dc.identifier.urihttps://hdl.handle.net/10568/134506
dc.titleExploiting genomics for antimicrobial resistance surveillance at One Health interfacesen
dcterms.abstractThe intersection of human, animal, and ecosystem health at One Health interfaces is recognised as being of key importance in the evolution and spread of antimicrobial resistance (AMR) and represents an important, and yet rarely realised opportunity to undertake vital AMR surveillance. A working group of international experts in pathogen genomics, AMR, and One Health convened to take part in a workshop series and online consultation focused on the opportunities and challenges facing genomic AMR surveillance in a range of settings. Here we outline the working group's discussion of the potential utility, advantages of, and barriers to, the implementation of genomic AMR surveillance at One Health interfaces and propose a series of recommendations for addressing these challenges. Embedding AMR surveillance at One Health interfaces will require the development of clear beneficial use cases, especially in low-income and middle-income countries. Evidence of directionality, risks to human and animal health, and potential trade implications were also identified by the working group as key issues. Addressing these challenges will be vital to enable genomic surveillance technology to reach its full potential for assessing the risk of transmission of AMR between the environment, animals, and humans at One Health interfaces. This is the fourth in a Series of five papers about harnessing genomics for antimicrobial resistance surveillance. All papers in the Series are available at www.thelancet.com/microbe.en
dcterms.accessRightsOpen Access
dcterms.audienceAcademicsen
dcterms.audienceScientistsen
dcterms.available2023-11-14
dcterms.bibliographicCitationMuloi, D.M., Jauneikaite, E., Anjum, M.F., Essack, S.Y., Singleton, D.A., Kasudi, M.R., Wade, M.J., Egyir, B., Nunn, J.G., Midega, J.T., Peacock, S.J., Feasey, N.A., Baker, K.S. and Zadoks, R.N. for the SEDRIC Genomics Surveillance Working Group. 2023. Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces. Lancet Microbe e1056–e1062.en
dcterms.extente1056–e1062en
dcterms.issued2023-12
dcterms.languageen
dcterms.licenseCC-BY-4.0
dcterms.publisherElsevieren
dcterms.subjectantimicrobial resistanceen
dcterms.subjectgenomicsen
dcterms.subjectone health approachen
dcterms.typeJournal Article

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: